...
首页> 外文期刊>Developments in Biologicals >Successful Development and Validation of an in Vitro Replacement Assay for Leptospira Vaccine Potency Tests
【24h】

Successful Development and Validation of an in Vitro Replacement Assay for Leptospira Vaccine Potency Tests

机译:钩端螺旋体疫苗效价测试的体外替代测定的成功开发和验证

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The standard requirement for serial release potency testing of Leptospira bacterins in the United States is the hamster vaccination challenge test. It is a test that uses a large number of animals experiencing pain or distress, takes weeks to conduct, can be expensive and requires that laboratory personnel handle a viable zoonotic pathogen. In an effort to address these concerns, the United States Department of Agriculture (USDA) developed an in vitro method for potency testing of four Leptospira serovars. This enzyme-linked immunosorbent assay (ELISA) was subsequently validated in the target species. USDA informed their biologies licensees, permittees and applicants of the availability of reference bacterins and the regulatory acceptance regarding this alternative test method in notices issued in 2007 and 2009. This presentation describes how the initial research and subsequent development and validation work were accomplished.
机译:在美国,对钩端螺旋体细菌进行连续释放效力测试的标准要求是仓鼠接种挑战测试。该测试使用大量遭受疼痛或困扰的动物,需要花费数周的时间进行,价格昂贵,并且需要实验室人员处理活的人畜共患病原体。为了解决这些问题,美国农业部(USDA)开发了一种体外方法,用于对四种钩端螺旋体血清型的效力进行测试。随后在目标物种中验证了这种酶联免疫吸附测定(ELISA)。美国农业部在2007年和2009年发布的通知中告知了其生物执照持有人,被许可人和申请人有关参考细菌的供应以及该替代测试方法的监管认可。此演讲介绍了初步研究以及后续开发和验证工作的完成方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号